European Commission approves Roche's fixed-duration Columvi

Basel, 11 July 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has granted conditional marketing authorisation for…

Related Keywords

Switzerland , Japan , United States , Australia , Melbourne , Victoria , Canada , America , Loren Kalm , Michael Dickinson , Nathalie Altermatt , Kirti Pandey , Karsten Kleine , Sileia Urech , Levi Garraway , Roche Group , Peter Maccallum Cancer Centre , European Commission , Head Of Global Product Development , Genentech , Roche Group Media Relations , European Medicines Agency Summary Of Product Characteristics , Drug Administration , World Health Organization , Chief Medical Officer , Global Product , Associate Professor , Royal Melbourne Hospital , New England Journal , Fixed Duration Columvi , Dow Jones Sustainability Indices , Chugai Pharmaceutical , European Medicines Agency Summary , World Health , Cancer Incidence , Refractory Diffuse Largeb Cell ,